In ₹ Crore except Per Share Latest Annual | BIOFILCHEM FY26 | MANGALAM FY26 | VINEETLAB FY26 | LASA FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | ◆ 21.05× | — | 36.00× | — | 36.00× -42% | |
| P/B | 2.72× | ◆ 0.54× | 1.52× | 0.69× | 0.69× +294% | |
| EV/EBITDA | 94.77× | ◆ -10.74× | 11.53× | -1.54× | -1.54× +6270% | |
| Market Cap | ₹58.6 Cr | ₹55.2 Cr | ₹69.2 Cr | ₹34.2 Cr | ₹55.2 Cr +6% | |
| Growth | ||||||
| Revenue CAGR 3Y | ◆ -1.85% | — | -34.59% | -42.11% | -38.35% +95% | |
| Revenue CAGR 5Y | ◆ -4.50% | — | -24.58% | -34.11% | -29.34% +85% | |
| Net Income CAGR 3Y | ◆ 70.67% | — | 8.59% | — | 8.59% +723% | |
| Revenue YoY (latest Q) | ◆ 91.99% | -0.40% | 34.21% | -93.87% | -0.40% +23098% | |
| Net Income YoY (latest Q) | -95.47% | 44.64% | ◆ 111.58% | 83.05% | 83.05% -215% | |
| Profitability | ||||||
| EBITDA Margin | 2.29% | -6.42% | ◆ 14.27% | -112.98% | -6.42% +136% | |
| Net Income Margin | ◆ 9.81% | -19.13% | 2.70% | -135.60% | -19.13% +151% | |
| Return on Common Equity | ◆ 12.92% | -43.08% | 3.52% | -68.70% | -43.08% +130% | |
| Return on Capital Employed | 1.70% | -27.98% | ◆ 10.55% | -69.54% | -27.98% +106% | |
| Return on Assets | ◆ 6.50% | -14.10% | 1.29% | -51.44% | -14.10% +146% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.14× | 1.02× | 0.99× | 0.20× | 0.99× -86% | |
| Interest Coverage | ◆ 37.37× | -2.04× | 1.24× | -89.13× | -2.04× +1932% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹28.4 Cr | ₹232 Cr | ₹59.4 Cr | ₹25.1 Cr | ₹59.4 Cr -52% | |
| Net Income | ₹2.8 Cr | −₹44.4 Cr | ₹1.6 Cr | −₹34.1 Cr | −₹34.1 Cr +108% | |
| Total Assets | ₹42.8 Cr | ₹315 Cr | ₹125 Cr | ₹66.3 Cr | ₹125 Cr -66% | |
| EPS | ₹1.71 | ₹-28.05 | ₹1 | ₹-6.8 | ₹-6.8 +125% | |
| Book Value per Share | ₹13.25 | ₹65.11 | ₹23.74 | ₹9.9 | ₹23.74 -44% | |